Documents

The impact of the COVID-19 response on the supply chain, availability and cost of generic antiretroviral medicines for HIV in low- and middle-income countries

22 June 2020

The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.

Download PDF
Email this link to me

Related

Empowering youth to lead Togo’s HIV response

31 October 2024

Peru approves groundbreaking law to extend health coverage for migrants with HIV and TB

21 October 2024

Can this innovation change the way people think about HIV?

16 October 2024